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Abstract:  Mycotoxins are toxic compounds, produced by the secondary metabolism of 
toxigenic moulds in the Aspergillus, Alternar ia, Claviceps , Fusarium , Penicilliu m  and 
Stachybotrys genera occurring in food and feed commodities both pre- and post-harvest. 
Adverse human health effects from the consumption of mycotoxins have occurred for 
many centuries. When ingested, mycotoxins may cause a mycotoxicosis which can result 
in an acute or chronic disease episode. Chronic conditions have a much greater impact, 
numerically, on human health in general, and induce diverse and powerful toxic effects in 
test systems: some are carcinogenic, mutagenic, teratogenic, estrogenic, hemorrhagic, 
immunotoxic, nephrotoxic, hepatotoxic, dermotoxic and neurotoxic. Although mycotoxin 
contamination of agricultural products still occurs in the developed world, the application 
of modern agricultural practices and the presence of a legislatively regulated food 
processing and marketing system have greatly reduced mycotoxin exposure in these 
populations. However, in developing countries, where climatic and crop storage conditions 
are frequently conducive to fungal growth and mycotoxin production, much of the 
population relies on subsistence farming or on unregulated local markets. Therefore both 
producers and governmental control authorities are directing their efforts toward the 
implementation of a correct and reliable evaluation of the real status of contamination of a 
lot of food commodity and, consequently, of the impact of mycotoxins on human and 
animal health. 
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1. A Widespread Problem 
Mycotoxins are a structurally diverse group of mostly small molecular weight compounds, 
produced by the secondary metabolism of some filamentous fungi or moulds [1,2], which under 
suitable temperature and humidity conditions, may develop on various foods and feeds, causing serious 
risks for human and animal health [3,4]. In terms of structural complexity, mycotoxins vary from 
simple C4
 compounds, e.g., moniliformin, to complex substances such as the phomopsins [5] and the 
tremorgenic mycotoxins [6]. Although currently more than 300 mycotoxins are known, scientific 
attention is focused mainly on those that have proven to be carcinogenic and/or toxic. Human exposure 
to mycotoxins may result from consumption of plant-derived foods that are contaminated with toxins, 
the carryover of mycotoxins and their metabolites in animal products such as meat and eggs [7] or 
exposure to air and dust containing toxins [8]. During the last 15–20 years, case studies have shown 
that people living and working in damp or moldy buildings have an increased risk of adverse health 
effects including impaired immune function, bronchitis, asthma, recurrent airway infections, and 
extreme fatigue [9]. More recently, the presence of Stachybotrys chartarum has been associated with 
the development of idiopathic pulmonary hemosiderosis (IPH) in infants, although the active toxins 
and mechanisms of exposure remain unclear [10].  
Human food can be contaminated with mycotoxins at various stages in the food chain [11,12] and 
the most important genera of mycotoxigenic fungi are Aspergillus, Alternaria, Claviceps, Fusarium, 
Penicillium and Stachybotrys. The principal classes of mycotoxins include a metabolite of Aspergillus 
flavus and Aspergillus parasiticus, aflatoxin B1 (AFB1), the most potent hepatocarcinogenic substance 
known, which has been recently proven to also be genotoxic. In dairy cattle, another problem arises 
from the transformation of AFB1 and AFB2 into hydroxylated metabolites, aflatoxin M1 and M2 (AFM1 
and AFM2), which are found in milk and milk products obtained from livestock that have ingested 
contaminated feed [13]. Ochratoxin A (OTA) is a secondary metabolite produced by several species of 
Aspergillus and Penicillium  fungi. The toxin, which is a nephrotoxic and nephrocarcinogenic 
compound, has mainly been found in cereals as well as in other products like coffee, wine, dried fruits, 
beer and grape juice. It occurs in the kidney, liver and blood of farm animals by transfer from animal 
feed. Although its genotoxic power has so far not been definitively established, zearalenone (ZEA), 
produced by various species of Fusarium, in particular F. graminearum  and F. culmorum, has an 
estrogenous action and is significantly toxic to the reproductive system of animals.  
The trichothecenes (TCT), are a family of 200–300 related cyclic sesquiterpenoids produced by 
Fusarium, Myrote cium, Trichoderma , Cephalosporium , Verticimonosporium ,  and  Stachybotrys 
species, which are divided into four groups (types A–D) according to their characteristic functional 
groups. Type-A and –B trichothecenes are the most common. Type A is represented by HT-2 toxin and  
T-2 toxin and type B is most frequently represented by DON, 3-acetyl-DON (3-Ac-DON), 15-acetyl-
DON (15-Ac-DON), nivalenol (NIV), and fusarenon X (FUS-X). Type C and D trichothecenes are 
characterized by a second epoxide (C-7,8 or C-9,10) or an ester-linked macrocycle   Toxins 2010, 2                 
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(C-4,16), respectively, and are not associated with Fusarium head blight (FHB). The toxic effects of 
trichothecenes include gastrointestinal effects such as vomiting, diarrhea and bowel inflammation. 
Anemia, leukopenia, skin irritation, feed refusal and abortion are also common. The trichothecenes as 
a group are immunosuppressive. The Fumonisins is (FUM) family of mycotoxins produced by the 
species of Fusarium in the Liseola section. F. verticilloides (formerly F. moniliforme), a species that is 
almost ubiquitous in corn, and F. proliferatum  are the main species producing high yields of FUM. 
Fumonisins B1, B2 and B3 (FB1, FB2 and FB3) occur in fungal cultures or are found in naturally 
contaminated corn samples. FUM are structurally similar to sphingosine, a component of 
sphingolipids. Sphingolipids are in high concentrations in myelin and in certain nerve tissues. FUM 
toxicity is thought to result from blockage of sphingolipid biosynthesis. FUM has been shown to cause 
leucoencephalomalacia in horses (ELEM), pulmonary edema in swine (PPE) and hepatoxicity   
in rats [14]. 
In the mid 1980s, the topic of conjugated or masked mycotoxins received attention, because in 
some cases of mycotoxicoses, clinical observations in animals did not correlate with the low 
mycotoxin content determined in the corresponding feed. The unexpected high toxicity was attributed 
to undetected, conjugated forms of mycotoxins that hydrolyze the precursor toxins in the digestive 
tract of animals. As part of their metabolism, plants are capable of transforming mycotoxins into 
conjugated forms [15–17]. So far, natural occurrence of a zearalenone glucoside [18] and 
deoxynivalenol glucoside [16–18] have been reported. Gareis [19] demonstrated that zearalenone-4-
beta-d-glucopyranoside was decomposed during digestion, releasing zearalenone into the animal gut. 
As zearalenone-glycoside is not detected during routine analysis but is hydrolyzed during digestion, it 
seems likely that masked mycotoxins may contribute to cases of mycotoxicoses. High-performance 
liquid chromatography (HPLC) combined with tandem mass spectrometry (MS/MS) offers a powerful 
tool for identification and characterization of mycotoxin conjugates [15].  
The impact of mycotoxins on health depends on the concentration and duration of exposure to the 
toxin, the toxicity of the compound, e.g., acute or chronic (e.g., carcinogenic) effects, the body weight 
of the individual, the presence of other mycotoxins (synergistic effects), environmental factors (farm 
management) and other dietary effects [20,21]. The incidence and extent of mycotoxin contamination 
is strictly related to geographic and seasonal factors as well as cultivation, harvesting, stocking, and 
transport conditions [22]. The evaluation of the incidence and extent of contamination of foodstuffs is 
crucial and has, in fact, been taken into account for many years by the various disciplines that concur 
in the definition and management of the risk associated with these toxins and its management [23]. 
2. Mycotoxin Occurrence and the Implications for Human and Animal Health  
A wide range of commodities can be contaminated with mycotoxins both pre- and post-harvest [7]. 
Aflatoxins (AFTs) are found in maize and peanuts, as well as in tree nuts and dried fruits. OTA is 
found mainly in cereals, but significant levels of contamination may also occur in wine, coffee, spices 
and dried fruits. Other products of concern are beans, roasted coffee and cocoa, malt and beer, bread 
and bakery products, wines and grape juices, spices, poultry meat and kidneys, pig kidneys and pork 
sausages [24–30]. OTA and AFB1 are among the most frequently observed combinations of 
mycotoxins in different plant products [31]. Most mycotoxins are relatively heat-stable within the Toxins 2010, 2                 
 
 
575
range of conventional food processing temperatures (80–121 °C), so little or no destruction occurs 
under normal cooking conditions such as boiling and frying, or even following pasteurization. In fact, 
during the production of cheese and other types of milk products the amount of AFM1 may increase 
(depending on the type of cheese). Available evidence suggests that tissue accumulation of these 
mycotoxins, or their metabolites, is very low and is excreted into milk from 1–6% of dietary intake 
[13,32,33]. Residues of cyclopiazonic acid (CPA), a co-contaminant with aflatoxin, have been found in 
meat, milk and eggs [34].  
Fusariotoxins are commonly found in cereals and their products, which constitute an important part 
of human food and animal feed. Highly contaminated crops are frequently directed to animal feed  
[35–37]. ZEA is a secondary fungal metabolite produced by several species of Fusarium fungi, mainly 
by F. graminearum and F. culmorum. These species are known to colonize maize, barley, oats, wheat, 
and sorghum, and tend to develop during prolonged cool, wet growing and harvest seasons in the 
temperate and warm regions of the world. Main animal and human exposure comes from chronic 
contaminated food ingestion but human exposure can be direct via cereals or indirect via animal 
products. As fusariotoxins are hydrosoluble, they are generally weakly accumulated in animal tissues 
[38]. Consequently, the possible presence of toxic residue in animal products (milk, meat, etc.) remains 
unclear. Trichothecenes are rapidly and dramatically eliminated without accumulation in organisms 
[39]. Only compound traces could still be detected 24 h after oral exposure. After an extensive review 
of the literature, Pestka [40] concluded that trace levels of mycotoxins and their metabolites may carry 
over into the edible tissue (meat) of food producing animals.  
Although most reports of mycotoxicoses have been associated with ingestion of infected food, there 
is evidence that airborne mycotoxins from indoor molds can also produce human illness, most likely 
caused by inhalation [44]. Health concerns relating to indoor molds have dramatically risen over the 
past decade. Indoor molds are perceived by many to be a growing problem in the USA, Canada and 
Europe [41–43]. Case studies have shown that people living and working in damp or moldy buildings 
suffer from very similar vague complaints such as airway infections, impaired immune function, 
bronchitis, asthma, irritation of eyes and extreme fatigue. These effects have come to be called ‘Sick 
Building Syndrome’, which means that no specific etiological factor can be identified. Molds growing 
on building materials can be divided into three groups based on their water activity (aw), requirements 
on laboratory substrates, and responses to changes in aw [45]. Primary colonizers or storage molds, 
capable of growing at aw < 0.8 (many with optimal growth rates at aw) approaching Penicillium 
chrysogenum and Aspergillus versicolor  are the most common species. Secondary colonizers or 
phylloplane fungi, requiring a minimal aw between 0.8 and 0.9. This group comprises species of 
Alternaria, Cladosporium, Phoma, and Ulocladium. These are able to thrive under conditions where 
marked changes in humidity occur during the day. Tertiary colonizers or water-damage molds, needing 
aw > 0.9, include many of the most toxic species such as Chaetomium  globosum, Memnoniella 
echinata, Stachybotrys chartarum , and species of Trichoderma. Several of these are considered 
tropical fungi, which seems consistent with their propensity for growth in humid buildings. Studies 
concerning indoor health problems and mycotoxins mainly focus on trichothecenes. It has been shown 
that isolates from fungi-damaged buildings produce highly cytotoxic trichothecenes (verrucarins, 
roridins, verrucarols, T-2 toxin, diacetoxyscirpenol, nivalenol and deoxynivalenol), but also ochratoxin 
A, zearalenone, aflatoxins and sterigmatocystin [9,35,46–48]. Toxins 2010, 2                 
 
 
576
In general, mycotoxin exposure is more likely to occur in parts of the world where poor methods of 
food handling and storage are common, where malnutrition is a problem, and where few regulations 
exist to protect exposed populations. However, even in developed countries, specific subgroups may 
be vulnerable to mycotoxin exposure. In the United States, for example, Hispanic populations consume 
more corn products than the rest of the population, and inner city populations are more likely to live in 
buildings that harbor high levels of molds [49]. 
Although hundreds of mycotoxins have been identified, information about many of them is limited 
with regard to their natural occurrence, stability in foods and feeds, and toxicity to humans and 
animals. In view of the diversity of toxicological manifestations and the economic losses after 
exposure to certain mycotoxins, there is a continuous need to protect the health of humans and 
susceptible animals by limiting their exposure to these toxins.  
AFB1 has been extensively linked to human primary liver cancer (PLC) [50], in which it acts 
synergistically with hepatitis B virus (HBV) infection and was classified by the International Agency 
for Research on Cancer (IARC) as a human carcinogen (group 1 carcinogen) [51]. This combination 
represents a heavy cancer burden in developing countries. Hepatocellular carcinoma (HCC) is the sixth 
most common cancer worldwide with 626,000 new cases in 2002 (5.7% of the total) [52]. Mortality is 
almost synonymous with incidence, given the poor survival rates. In 2002 there were 598,000 deaths in 
the world from HCC. The majority of HCC cases (>80%) occur in developing countries with a higher 
incidence in males than females. In Europe, the incidence rates for HCC are generally low. Given 
recently published liver cancer incidence rates in the European Union of 10.0 per 100,000 males and 
3.3 per 100,000 females [53], it is clear that aflatoxin plays a significant role in liver cancer in 
developing countries, but not in the developed world where other risk factors such as cirrhosis are 
more important. AFM1, according to the classification of IARC [51], was first classified in the second 
group of carcinogens (2B), but in the year 2002 [50], the same organization classified it in the first 
group of carcinogens. AFB1, however is a genotoxic, carcinogen and the safety factors used for non-
genotoxic carcinogens cannot apply. Therefore, most agencies have not set a Tolerable Daily Intake 
(TDI) for AFB1. AFB1 is moreover considered the main hepatocarcinogen in animals, although effects 
vary with species, age, sex, and general nutritional conditions. Trout, ducklings and pigs are highly 
susceptible, with ruminants being less susceptible [54]. Fumonisin B1 (FB1) is always the most 
abundant and toxic metabolite of this group of mycotoxins, representing ca. 70% of the total 
concentration in naturally contaminated foods and feeds, followed by FB2 and B3. FUM 's are 
structurally similar to sphingolipids and their bases, and they inhibit ceramide syntethase, an enzyme 
in their biosynthetic pathway. This inhibition results in increased levels of sphingoid bases 
(sphinganine and sphingosine) in serum of exposed animals. FUM have been implicated in one 
incident of acute food-borne disease in India in which the occurrence of borborygmy, abdominal pain, 
and diarrhea was associated with the consumption of maize and sorghum contaminated with high 
levels of FUM [55]. FB1, the most abundant of the numerous FUM analogs, was classified by the 
IARC as a group 2B carcinogen (possibly carcinogenic in humans) [53]. Studies in the former 
Transkei region of South Africa and in Linxian and Cixian counties, China, have demonstrated an 
association between FUM exposure in rural subsistence farming areas and a high incidence of 
esophageal cancer as well as with field outbreaks of ELEM in many countries such as Egypt, South 
Africa and the United States of America [56] and pulmonary edema in swine (PPE) [57,58]. ELEM is Toxins 2010, 2                 
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a fatal neurological disease of horses, characterized by liquefactive necrosis of the white matter of the 
brain. ELEM has been experimentally induced in horses by either supplementing their diets with F. 
moniliforme-contaminated corn, or by the oral administration of FB1, a toxin produced by F. 
moniliforme [59]. FUMs, which inhibit the uptake of folic acid via the folate receptor [60], have also 
been implicated in the high incidence of neural tube defects in rural populations known to consume 
contaminated maize, such as the former Transkei region of South Africa and areas of northern China 
[61]. Besides their hepatotoxicity [62] and nephrotoxicity [63], they affect also the immune system 
[64,65]. Risk assessments for FUMs have been performed by the Scientific Committee on Food (SCF) 
[66], the Joint FAO/WHO Expert Committee on Food Additives (JECFA) [67] and a Nordic Working 
Group [68]. A group provisional maximum tolerable daily intake (PMTDI) for FB1, FB2 and FB3 of 2 
mg/kg body weight was established by JECFA. A group TDI of 2mg/kg body weight was also 
established by SCF [66]. The tolerable intake established by JECFA and SCF was based on a no-
observed-adverse effect level (NOAEL) of 0.2 mg FB1/kg body weight/day for kidney toxicity in the 
rat, the most sensitive adverse effect observed. The presence of other fusariotoxins, such as 
moniliformin or culmorin, is only rarely reported so they will not be evoked here.  
The other three agriculturally important mycotoxins have also been associated with various 
outbreaks of human disease, mostly in developing countries. A number of occurrences of acute food-
borne illness in India and China involving gastrointestinal symptoms have been attributed to the 
consumption of deoxynivalenol (DON)-contaminated cereals [69,70]. TCT are responsible for a wide 
range of disorders in animals, including feed refusal, weight loss and vomiting. An extensive 
toxicological evaluation of TCT in animal feed was conducted by Eriksen and Pettersson [71]. In 
particular, DON inhibits protein biosynthesis and has been reported to suppress immune responses 
[72]. Higher intakes than the recommended TDI (1 mg kg 
-1 bodyweight day 
-1) were recognized, 
especially for infants and children, and indicated clearly that the presence of T-2 and HT-2 should be 
of concern for public health [73]. OTA has long been associated with Balkan endemic nephropathy 
(BEN), a fatal renal disease with histopathological similarities to OTA-induced nephropathy in swine 
and has been associated with incidences of epithelial tumors of the upper urinary tract [74,75]. OTA 
was classified by the IARC as possibly carcinogenic to humans (group 2B carcinogen) [76]. The 
European legislation estimated the TDI for OTA at 5.8 ng OTA kg
-1 body weight per day [77]. 
However, as there are differences in food intake (per unit of body weight) for children, adolescents and 
adults, for a given concentration of a contaminant, a child or an adolescent will receive different 
exposure than an adult. The only estrogenic mycotoxins yet established are the zearalenones, although 
there is no reason to believe that other structural classes will not be discovered in the future. ZEA is a 
naturally occurring endocrine-disrupting chemical and has been associated with clinical manifestations 
of various estrogenic effects in humans and farm animals, especially pigs [78], including an outbreak 
of precocious pubertal changes in young children in Puerto Rico in the Caribbean [79] and 
gynecomastia with testicular atrophy in rural males in southern Africa [80]. ZEA is, therefore, a 
frequently analyzed mycotoxin, and analysis of ZEA has been included in the internal quality control 
of maize production by many cereal handling companies. Besides sampling, the major problems for 
regulation and control of the ZEA content have so far been the lack of fast analytical methods and a 
lack of comparability of measurement results and of appropriate reference materials. Toxins 2010, 2                 
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Various mycotoxins may occur simultaneously, depending on the environmental and substrate 
conditions [81]. Considering this coincident production, it is very likely that humans and animals are 
exposed to mixtures rather than to individual compounds. The interactive (synergistic) cytotoxic 
effects of OTA, Ochratoxin B (OTB), citrinin, and patulin, which are produced by a number of 
Penicillium and Aspergillus species, was recently evaluated by Heussner et al. [82]. By application of 
a step-wise approach to test combination toxicity, using various full factorial as well as a central 
composite experimental design, the interactive (synergistic) cytotoxic effects of the these four toxins 
were assessed. These findings indicate that the toxicity of mycotoxin mixtures cannot be accurately 
predicted only on the basis of the effect of the individual toxins. These aspects must be considered in 
future risk assessment studies.  
The evaluation of mycotoxins in biological fluids can provide useful indications of the dietary 
intake of mycotoxins. This approach can also constitute a valid, although indirect, evaluation of 
mycotoxin contamination in foodstuffs. This methodology can somehow give a better estimate of the 
exposure of humans to mycotoxins than that obtained by monitoring food data since the latter may, as 
stated, be affected by sampling, subsampling, and analysis errors.  
3. The Importance of Mycotoxin Control 
Mycotoxins are secondary metabolites of fungi. It is not possible to predict their presence or to 
prevent their occurrence during preharvest, storage, and processing operations by current agronomic 
practices. Therefore, their presence in food and feed represents a constant health risk for animals and 
humans. Regulations relating to mycotoxins have been established in many countries to protect the 
consumer from the harmful effects of these compounds. In several countries, these contaminants are 
subject to legislation that is based on the establishment of an Acceptable daily intake (ADI) or 
Tolerable daily intake (TDI). Different factors play a role in the decision-making process of setting 
limits for mycotoxins. These include:  
–  the availability of toxicological data on mycotoxins,  
–  the availability of exposure data on mycotoxins,  
–  knowledge of the distribution of mycotoxin concentrations within commodity or product lots,  
–  the availability of analytical methods,  
–  legislation in other countries with which trade contacts exist,  
–  the need for sufficient food supply.  
The first two factors provide the information necessary for hazard assessment and exposure 
assessment, respectively; the main bases of risk assessment. Risk assessment is the scientific 
evaluation of the probability of the occurrence of known or potential adverse health effects resulting 
from human exposure to food-borne hazards. It is the primary scientific basis for promulgation of 
regulations. The third and fourth factors are important for enabling practical enforcement of mycotoxin 
regulations through adequate sampling and analysis procedures. The last two factors are merely socio-
economic in nature, but are equally important in the decision-making process to establish meaningful 
regulations and limits for mycotoxins in food and feed. Risk assessment regulations are primarily 
based on known toxic effects. For the mycotoxins currently considered most significant (AFB1, B2, G1
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and G2; AFM1; OTA; patulin; FB1, FB2, and FB3, ZEA, T-2, HT-2 toxins and DON), the Joint Expert 
Committee on Food Additives (JECFA-Scientific Advisory Body of the World Health Organization 
WHO) and the Food and Agriculture Organization (FAO) has evaluated their hazard in several 
sessions [83–85]. In February 2001, a special JECFA session was devoted to emergency mycotoxins. 
Two reports have appeared following this session: a longer version [86] and a shorter version [87]. 
These reports provide good and detailed insight into the process of risk assessment of mycotoxins. The 
reports addressed several concerns about the mycotoxins considered - their properties and metabolism, 
toxicological studies, and final risk evaluation. With the mycotoxin evaluations, the Committee 
discussed general considerations on sampling, analytical methods associated intake issues and control. 
Risks associated with mycotoxins depend on both hazard and exposure. The hazard of mycotoxins to 
individuals is probably, more or less, the same all over the world (although other factors are, 
sometimes, also important, e.g., hepatitis B virus infection in relation to the hazard of aflatoxins). 
Exposure is not the same due to different levels of contamination and dietary habits in various parts of 
the world. The risk analysis framework for food safety is illustrated in Figure 1. 
Figure 1. Risk analysis framework for food safety. 
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representative sample is the most critical stage. Thus, the error associated with sampling procedures is 
notably higher than that associated with subsampling or analysis.  
Sampling is one of the most crucial, but underestimated parts of the multifaceted and complex bulk 
of activities aimed at addressing and managing food issues. In practice, the overall objective of good 
sampling is to provide reliable samples to be analyzed that can represent the basis for ‘‘fit for 
purpose’’ investigations. In most cases, meaningful sampling is a process comprising two very 
dissimilar steps 
(1)  The first step (hereafter referred to as ‘‘primary sampling’’) consists of taking the decision on 
“why, where and when” to collect the samples. In other words, the process of “statistically” 
locating the sites (populations) from which food samples should be taken;  
(2)  The second step (hereafter referred to as “secondary sampling”) consists of establishing how 
samples should be collected in order to be representative of the lot under investigation. For 
both steps, the quality and the consequent reliability of the data are strongly dependent on the 
available resources and on the skill of the people involved.  
For this class of contaminants, the need for statistically-based planning is particularly relevant for: 
(i) The multifaceted implications of mycotoxin contamination (health, trade, ethical issues related to 
developing countries’ difficulties), and (ii) the largely non-homogeneous distribution of the toxins 
within food commodities, with the consequent need for careful secondary sampling. Appropriate 
sampling plans are essential to ensure that the analytically-derived mean concentration of a sample is 
representative of the true mean concentration of a lot. Sampling plans are particularly relevant in the 
area of mycotoxins, where it is known that the contamination of a commodity can be heterogeneously 
distributed. Good primary sampling schemes have so far been developed for several classes of 
contaminants, such as dioxins and pesticides [88], in contrast to the very few valid ones so far 
proposed for mycotoxins. In contrast, a large number of papers have appeared related to secondary 
sampling schemes for AFB1 (particularly on its distribution in a lot and on related sampling plans) 
[89], but only a few studies deal with some Fusarium toxins [90,91]. Conversely, specific studies 
focused on the distribution of OTA-contaminated units are not yet available, apart from the vague 
assumption that ‘‘representative sampling’’ for aflatoxins is more difficult than sampling for other 
known mycotoxins in food products. Sampling procedures recommended for aflatoxins should thus be 
adequate for other mycotoxins [92]. Nevertheless, the European legislation dealing with sampling and 
methods of analysis of mycotoxins for official control was recently adopted [93].  
In conclusion, the analysis of sources of errors in evaluating the impact of mycotoxins on human 
health should be carefully performed taking into account many aspects such as planning and 
accomplishment of monitoring programs, consumer’s health protection, economic, political and 
commercial considerations.  
State-of-the-art analytical methods  
Legislation calls for monitoring methods. Reliable analytical methods must be available to enable 
enforcement of the regulations in daily practice. In addition to reliability, simplicity is desired, as it 
will affect the amount of data generated and the practicality of the ultimate measures taken. The Toxins 2010, 2                 
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reliability of mycotoxin analysis data can be improved by use of interlaboratory-validated methods of 
analysis (e.g., the methods of Association of Official Agricultural Chemists (AOAC) International and 
methods standardized by European Standardization Committee-CEN) (Figure 2). These methods have 
been largely developed in response to planned regulations for mycotoxins or regulations that came into 
force. The requirements for these methods were dictated by the needs, i.e., they had to be suitable for 
the (planned) regulated mycotoxin–matrix combination(s). The limits of determination of the methods 
had to be demonstrated to be low enough for precise and accurate determination of the mycotoxins of 
interest at regulatory levels. Methods were also developed and validated for toxin–matrix combinations 
for which there were no regulations (yet), but for which the scientific community saw a need, e.g., for 
surveillance purposes. These developments eased the establishment of specific mycotoxin regulations. 
AOAC currently has approximately 45 analytical methods for determination of mycotoxins [94]. All 
have undergone extensive testing in interlaboratory validation studies, and subsequent review by the 
AOAC’s rigorous approval process. AOAC methods are referred to as official methods in mycotoxin 
legislation in a few dozen countries [95]. In Europe, CEN methods are becoming increasingly 
important. Ten mycotoxin methods have been standardized by the CEN, and this number will grow 
substantially in the years to come. Although CEN mycotoxin methods are not mandatory for official 
food control in the European Union (EU), all CEN mycotoxin methods can be used in the EU for 
official food-control purposes because their performance characteristics fulfill the criteria laid down in 
the EU regulation for sampling and analysis [96]. One of them, HPLC with different detectors, is 
frequently used both for routine analyses and as a confirmatory method for novel or screening 
techniques. For some mycotoxins, e.g., TCT, gas chromatography (GC) is the method more often used 
[97]. Except for direct mass spectrometric methods, all the other analytical methods used for 
mycotoxin determination are either immunoassay based, or otherwise fall into the category of direct or 
indirect screening methods. The use of good, validated methods of analysis is no guarantee that 
reliable analytical results will be obtained in mycotoxin determination. Analytical quality assurance 
(AQA) is another prerequisite for adequate food-law enforcement. AQA includes, where possible, the 
use of (certified) reference materials (e.g., CRMs supplied by the irmm.jrc.be). European 
Commission’s Joint Research Centre/Institute for Reference Materials and Measurements 
(JRC/IRMM).  
Figure 2. Performance measurement, validation, and proficiency testing (Adapted from 98).  
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5. The International Mycotoxin Regulatory Situation  
Mycotoxins may be present in many foods, feeds and commodities as a result of growth of mould 
on crops and foods, sometimes in quantities below the limit of detection of the analytical methods of 
today. As foods, feeds and raw materials and ingredients for food production are to an increasing 
extent traded across borders, there is an evident need for international legislation on mycotoxins in 
foods and feeds in order to avoid trade barriers and to protect the health of the consumer. Since the 
discovery of the AFT in 1960 and subsequent recognition that mycotoxins are of significant health 
concern to both humans and animals, regulations gradually developed for mycotoxins in food and feed. 
In the early days of mycotoxin regulations these measures focused mainly on the aflatoxins. They were 
established by industrialized countries and limits often had an advisory or guideline character. Over the 
years, the number of countries with known specific mycotoxin regulations has increased from 33 in 
1981 [99] to 56 in 1987 [32], 77 in 1995 [100], and 100 in 2003 [95]. 
International legislation on foods and feeds is established by Codex Alimentarius (CAC). The 
Codex Alimentarius system for development of legislation concerning contaminants, including 
mycotoxins in foods and feeds, is laid down in considerable detail [101,102]. The Codex Committee 
on Food Additives (CCFAC) serves as the body responsible for the risk management component of the 
Codex Alimentarius risk analysis process in relation to contaminants in general and mycotoxins in 
foods and feeds in particular. The body responsible for the risk assessment component of the Codex 
Alimentarius risk analysis process is JECFA. It is the role and privilege of JECFA to provide Codex 
Alimentarius with scientifically based assessment of the toxicity of food additives and contaminants, 
such as mycotoxins, and to establish safe levels for human consumption. Hence, the 56th JECFA in 
February 2001 assessed several mycotoxins [86]. The Codex General Standards for Contaminants and 
Toxins in Food (GSCTF) covers also feeds and raw commodities. The GSCTF contains the most 
important principles for laying down Codex Maximum Limits (MLs) for contaminants and toxins in 
foods and feeds [103]. 
Current regulations encompass 13 different mycotoxins or groups of mycotoxins and specific limits 
have been established for many food and feed commodities and products. Until the late 1990s setting 
of mycotoxin regulations was mostly a national affair. Gradually, several economic communities e.g., 
EU, European Union; MERCOSUR Mercado Cómứn del Sur; Australia and New Zealand harmonized 
their mycotoxin regulations, thereby overruling existing national regulations. Current regulations are 
increasingly based on scientific opinions of authoritative bodies, for example the FAO/WHO Joint 
Expert Committee on Food Additives of the United Nations (JECFA) and the European Food Safety 
Authority (EFSA). At the same time, requirements for adequate sampling and analytical methods put 
high demands on other professional organizations, for example AOAC International and the European 
Standardization Committee (CEN).  
6. Economic Impact  
Mycotoxin contamination of the food chain has a major economic impact. However, the insidious 
nature of many mycotoxicoses makes it difficult to estimate incidence and cost [104]. In addition to 
crop losses and reduced animal productivity, costs are derived from the efforts made by producers and Toxins 2010, 2                 
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distributors to counteract their initial loss, the cost of improved technologies for production, storage 
and transport, the cost of analytical testing, especially as detection or regulations become more 
stringent, and the development of sampling plans [91]. Although in Europe there are no data on the 
economic costs of mycotoxins, for only Hungary the direct and indirect losses were estimated in a 
wheat epidemic (1998) to 100 million Euro. In the United States alone, the mean economic annual 
costs of farmer gate cereal crop losses due to aflatoxins, fumonisins and trichothecenes, are estimated 
to be $932 million. There is also a considerable cost to society as a whole, in terms of monitoring extra 
handling and distribution costs, increased processing costs and loss of consumer confidence in the 
safety of food products. It is estimated that in developing countries, the greatest economic impact is 
associated with human health [105].  
Delineating economic impact reflects the complexity of a mycotoxin contamination within the food 
chain. There is a clear need to protect consumers through regulations, but at what cost? A 
comprehensive risk and economic analysis of lowering the acceptable levels for FUM and AFT in 
world trade demonstrated that the United States would experience significant economic losses from 
tighter controls [106]. The developing countries, China and Argentina, were more likely to experience 
greater economic losses than sub-Sahara Africa. The disturbing outcome of this detailed analysis was 
that tighter controls were unlikely to decrease health risks and may have the opposite effect [106]. In 
other words, very stringent international trade regulations could lead to the situation where exporting 
countries, especially developing countries, would retain higher risk commodities which would 
subsequently be available for their own populations; communities which are already exposed to higher 
levels of mycotoxins than consumers in developed countries.  
7. Strategies to Prevent Mycotoxin Contamination of Food and Animal Feed  
Many strategies to prevent mycotoxin contamination of food and animal feed have been developed 
[107,108]. It is clear that mycotoxins can contaminate agricultural produce, both in the field as well as 
during storage. The use of pre-harvest control strategies for such resistance varieties, field 
management, the use of biological and chemical agents, harvest management and post-harvest 
applications, including improving drying and storage conditions, together with the use of natural and 
chemical agents and irradiation have clearly been shown to be important in the prevention of 
mycotoxigenic mould growth and mycotoxin formation [109]. The importance of drying and moisture 
control during storage is generally well understood by the industry, in terms of the importance of 
prevention of fungal contamination. Interesting results have been reported on the potential use of 
biocompetitive agents in different biological control strategies to prevent the pre-harvest aflatoxin 
contamination of crops, such as peanuts, rice, maize, and cottonseed. It is clear that much more work 
must be conducted to identify various crop genotypes which are resistant to mycotoxigenic fungus 
infection and subsequently mycotoxin formation. It is also clear that a combination of the development 
of crop species with resistance to toxigenic fungi and biocompetitive non-mycotoxigenic strain 
technologies may yield one of the most effective strategies for prevention of mycotoxin contamination 
[110,111]. Several natural plant extract and spice oils of eugenol, cinnamon, oregano, onions, 
lemongrass [112,113], tumeric, mint, and chemical compounds (fungicide, herbicide, and surfectant) 
are known to prevent both mycotoxigenic mould growth and mycotoxin formation during post-harvest Toxins 2010, 2                 
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season. In addition to application of plant extracts and chemical agents as well, sodium bisulfite, and 
chlorine seem to hold great potential in the detoxification of mycotoxins, unfortunately their use 
significantly decreases the nutritional value of the foods or produces toxic derivatives in the treated 
product with undesirable sensory properties. This will severely limit their widespread use. At the same 
time it should be noted that chemical treatment is not allowed within the EC for commodities destined 
for human consumption. Recently, there has been an increasing interest in the use of bacteria, yeast, 
and fungi to help reduce the toxic effect of mycotoxins [114]. While most studies to date on mycotoxin 
detoxification by microorganisms have been undertaken under laboratory conditions, there is data on 
the effective use of F. aurantiacum  in the detoxifying AFB as antagonistic microorganisms, such as 
lactic acid bacteria with their antifungal properties, seem to be potentially very effective in the 
prevention of mycotoxin formation. The precise antifungal properties of lactic acid bacteria are still 
largely unresolved but may involve microbial competition [115], as well as extracellular metabolites 
which are heat-stable and of low molecular weight. Again, further investigations are clearly needed to 
gain a better understanding of this antifungal action. Various physical and chemical strategies have 
also been developed to help prevent mycotoxin contamination, including physical separation, 
extraction with sorbents, and adsorption [116]. The fluorescence sorting of maize, cottonseed and figs 
by examination under UV light is known to be the cheapest and the simplest acceptable way for the 
screening of aflatoxins. It is clear that no single currently available physical or chemical detoxification 
method will be suitable for all foods and animal feeds. The effectiveness of a method in the 
detoxification of mycotoxins depends on the nature of the food, environmental conditions such as 
moisture content, temperature, as well as the type of mycotoxin, its concentration and the extent of 
binding between mycotoxin and constituents. While a range of chemical compounds, including 
hydrochloric acid, ammonia, hydrogen peroxide, ozone,
 from various food products, including milk, 
peanuts, maize, and red pepper without leaving toxic end products. One potential drawback here is the 
production of a bright orange pigment by the organisms which restricts its use in the detoxification of 
food and in feed fermentations. The most recent approach to the problem has been the use of 
mycotoxin-binding agents in the diet that sequester the mycotoxin in the gastrointestinal tract thus 
reducing their bioavailability. Although activated charcoal (AC), hydrated sodium calcium 
aluminosilicate (HSCAS), aluminosilicate, zeolite, and bentonite have shown good potential for use in 
the animal feed to help overcome aflatoxicosis, the future in vivo investigations must focus on other 
problematic mycotoxins. Interestingly lactic acid bacteria and bifidobacteria have been shown to bind 
AFB1, but mechanistic studies need to be conducted on the precise binding mechanism, while the 
conditions favoring the release of bound toxin molecules need to be investigated as well.  
8. Conclusions  
Toxic levels of many naturally occurring toxins are often produced only under certain 
environmental conditions. Identification and prevention of these environmental conditions will play an 
important role in minimizing the adverse effects of these toxins. However, because many of these 
environmental conditions cannot be controlled, surveillance testing of susceptible commodities will 
remain of vital importance. Increased production of cereals will be needed in the future to satisfy 
growing food demand in developing countries and feed demand in the newly industrializing countries. Toxins 2010, 2                 
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Under these circumstances, occurrence of mycotoxins in agricultural commodities will continue to 
remain on the health and economic policy agenda. The scope of the mycotoxin problem is readily 
understood when it is appreciated that there are many thousand secondary fungal metabolites, the vast 
majority of which have not been tested for toxicity or associated with disease outbreaks. Many fungi 
produce several mycotoxins simultaneously, especially Fusarium  species. Co-occurrence of 
mycotoxins is of special concern, for instance, in the case of FUM (cancer promoter) and AFT (a 
potent human carcinogen) where a complimentary toxicity mechanism of action occurs. In developing 
countries it is likely that consumers will be confronted with a diet that contains a low level of toxin and 
in many cases, there may be other toxins present.  
Implicit with these conclusions are the existence of syndromes of apparently unknown etiology and 
epidemiology that may involve mycotoxins and the difficulty of establishing "no effect" levels for 
mycotoxins. 
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